Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 11 16
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021 7 1
Zinc sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/16/2021 3 0
P10 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
P8 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
P9 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
Eribulin mesylate Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/10/2021 1 0
Excel (.xslx) CSV (.csv)